TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

PHE_Purchase of RapiPREP Nucleic Acid Extraction Kit

Medical kits
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Public Health England: "PHE_Purchase of RapiPREP Nucleic Acid Extraction Kit". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityPublic Health EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Public Health England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Public Health England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
3.3Bids / Report
71.2% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 58 active published awards; 52 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityPublic Health England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published18 Feb 2021, 22:56 GMT
Last source update18 Feb 2021, 22:56 GMT
Recurring procurementNot published
ClassificationMedical kits
Delivery area
UK
OCIDocds-h6vhtk-029454
What is being bought
The UK Government must protect the health and wellbeing of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 January 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020. PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health and Social Care within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the recent COVID -19 outbreak. The negotiated procedure without a prior publication has been used due to extreme urgency on the grounds of regulation 32(2)(c) as the purchase of RapiPREP Nucleic Acid Extraction Kit for Extractions and RapiPREP Viral Lysis Buffer for Swabs will provide additional lab capacity for Covid-19 activity.
What changed
From the official release history
  1. Status changed to complete
    18 Feb 2021, 22:56 GMT
  2. Official notice release published
    18 Feb 2021, 22:56 GMT
  3. Buyer information updated
    18 Feb 2021, 22:56 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Purchase of RapiPREP Nucleic Acid Extraction Kit for Extractions and RapiPREP Viral Lysis Buffer for Swabs to provide additional lab capacity for Covid-19 activity.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    18 Feb 2021, 22:56 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 21 Dec 2020, 00:00 GMT · £500,000
Commercial outcome and competition
Awards
Microsensdx Limited
Not published · Not published · active
Contracts
PHE_Purchase of RapiPREP Nucleic Acid Extraction Kit
£500,000 · signed 21 Dec 2020, 00:00 GMT · active
Bid statistics
bids: 1 (lot 1)
Buyer and organisations in this procedure

Public Health England

Contracting authority GB-FTS-2800
View buyer profile
  • Public Health England
    buyer

    Manor Farm Road, Porton Down, Salisbury, UK, SP2 0QT
    +44 2076548000
  • Microsensdx Limited
    supplier

    London Bioscience Innovation Centre, 2 Royal College Street NW1 0NH, London, UK, NW1 0NH
  • Public Health England
    reviewBody

    Wellington House, 133-155 Waterloo Road, London, SE1 8UG
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe UK Government must protect the health and wellbeing of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 January 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020. PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health and Social Care within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the recent COVID -19 outbreak. The negotiated procedure without a prior publication has been used due to extreme urgency on the grounds of regulation 32(2)(c) as the purchase of RapiPREP Nucleic Acid Extraction Kit for Extractions and RapiPREP Viral Lysis Buffer for Swabs will provide additional laboratory capacity for Covid-19 activity